Resultado de búsqueda
13 de jun. de 2024 · The Foundation fuels the future of Dr. Gonzalez's legacy by preserving, promoting and propagating his holistic individualized nutrition protocols in the education about the treatment and prevention of cancer and other degenerative diseases.
13 de jun. de 2024 · FULL STORY. The reason why targeted treatment for non-small cell lung cancer fails to work for some patients, particularly those who have never smoked, has been discovered by researchers from...
Hace 2 días · This is the first study, to the authors’ knowledge, to report that patients are willing to accept additional cytoreductive treatments to the prostate and metastases for progression-free and survival benefits. We report willingness to accept 10 percentage-point increases in urinary incontinence and fatigue to gain 3.4 and 2.7 mo of post-treatment survival time, respectively. These results can ...
13 de jun. de 2024 · A study shows that a targeted therapy drug stops the spread of lung cancer for 5 years or more. The drug, lorlatinib (Lobrena), also stops new cancer growth in the brain. These benefits were seen in 3 out of every 5 people with advanced non-small cell lung cancer (NSCLC) with an ALK gene mutation. “This sets a new bar for targeted ...
29 de jun. de 2024 · In “Fenbendazole and Cancer Part 1”, I covered all the mechanisms of action that Fenbendazole has shown against cancer in many in vitro and in vivo studies. The 10 new studies published in 2023-2024 only confirm what we already know from previous studies.
26 de jun. de 2024 · Colorectal cancer (CRC) is a major cause of cancer-related deaths globally. While treatment advancements have improved survival rates, primarily through targeted therapies based on KRAS, NRAS, and BRAF mutations, personalized treatment strategies for CRC remain limited. Immunotherapy, mainly immune checkpoint blockade, has shown efficacy in ...
22 de jun. de 2024 · When it comes to targeted therapies for the treatment of lung cancer, “the future of precision medicine is here,” as Dr. Ravi Salgia explained during the CURE® Educated Patient® Lung Cancer Summit.
